New hope for rare, severe blood vessel disease as trial tests promising drug
NCT ID NCT07477795
Summary
This study is testing if a drug called secukinumab can help control severe Takayasu arteritis, a rare disease that causes dangerous inflammation in the body's largest blood vessels. It will involve 52 patients with active, severe disease to see if the drug can achieve remission and allow them to stop taking steroid medications, which often cause serious side effects. The goal is to find a more targeted treatment for this difficult-to-manage condition.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TAKAYASU ARTERITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.